Log In
Print
BCIQ
Print
Print this Print this
 

recAP (recombinant alkaline phosphatase)

  Manage Alerts
Collapse Summary General Information
Company AM-Pharma B.V.
DescriptionIV recombinant human alkaline phosphatase
Molecular Target Lipopolysaccharide (LPS)
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$600.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today